Bridging the Scientific Gaps to Identify Effective Treatments in Adrenocortical Cancer
Adrenocortical cancer (ACC) typically presents in advanced stages of disease and has a dismal prognosis. One of the foremost reasons for this is the lack of available systemic therapies, with mitotane remaining the backbone of treatment since its discovery in the 1960s, despite underwhelming efficac...
Main Authors: | Nicholas Michael, Naris Nilubol |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-10-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/14/21/5245 |
Similar Items
-
Adrenocortical neoplasms in children: Treatment and outcomes
by: Vishesh Jain, et al.
Published: (2022-01-01) -
Laparoscopic or Open Adrenalectomy for Stage I–II Adrenocortical Carcinoma: A Retrospective Study
by: Martin Gaillard, et al.
Published: (2023-05-01) -
Surgical Management of Adrenocortical Carcinoma: Current Highlights
by: Giuseppe Cavallaro, et al.
Published: (2021-07-01) -
RESULTS OF DIAGNOSTICS AND TREATMENT OF ADRENOCORTICAL CANCER
by: P. N. Romashchenko, et al.
Published: (2015-06-01) -
GIANT NON-FUNCTIONING ADRENOCORTICAL CARCINOMA
by: Ivandy Fam, et al.
Published: (2023-01-01)